DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Olanzapine (Excl. Dafo. for the Production of a Depot - Isu, Atc N05ah03 (Obo) F. 01.08.24 - 31.07.26. The project location is Germany and the tender is closing on 05 Jun 2026. The tender notice number is -, while the TOT Ref Number is 102813917. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Olanzapine (Excl. Dafo. for the Production of a Depot - Isu, Atc N05ah03 (Obo) F. 01.08.24 - 31.07.26

Deadline : 05 Jun 2026

Other Information

Notice Type : Tender

TOT Ref.No.: 102813917

Document Ref. No. : Login to see details

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : EUR 1.00

Purchaser's Detail

Name : Login to see details

Address : Login to see details

Email : Login to see details

  Login to see details

Documents

 Tender Notice